Skip to main content
Premium Trial:

Request an Annual Quote

BioDiscovery, Genops Ink Plan to Integrate IT Platforms

NEW YORK, Feb. 27 - BioDiscovery and Genops Bioinformatics have announced plans to integrate their platform products.


The companies say the plan is to integrate BioDiscovery's GeneDirector with Genops' Ngene software and Linux cluster platform for high-throughput sequence analysis and annotation.

The firms explain that the goal of their agreement is "to provide a seamless product for integrated gene expression analysis." Both Ngene and GeneDirector have been designed as "expandable platforms" that can handle genomic- and proteomic-data integration.


Financial terms of the agreement were not disclosed.


"Our partnership aims to provide a cohesive data, experiment, and knowledge management core with the ability to ... analyze, compare, and annotate information generated from array experiments.... ," Soheil Shams, BioDiscovery's CEO, said in a statement.


This is not the first deal of its kind for Genops. Last September, the Vancouver, British Columbia-based company and bioinformatics startup Zerosum penned an information-sharing partnership designed to help Genops broaden its Ngene software while at the same time boost Zerosum's burgeoning business.


The deal also will help Zerosum, of Seven Valleys, Penn., expand its Bioinformatics Infrastructure Operations Center's life-science computing services.

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.